Atlas Trials

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

Clinical trial NCT00671671 · COMPLETED

Trial details

NCT number
NCT00671671
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis, ChronicHepatitis C Virus
Start date
2008-04-01
Primary completion
2008-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.